SEO URLwww.firestrike.ai/deals/aktis-oncology-lilly-acquisition-2026
acquisitionAnnounced · Jan 7, 2026PharmaceuticalsSource · Community DiscussionsArticle · Expectations
Lilly acquires Aktis Oncology
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Aktis Oncology
NASDAQ: AKTS · Boston, Massachusetts
Acquirer
Lilly
Status
—
Lilly agreed to acquire Aktis Oncology. Reported deal value: Undisclosed. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Boston, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
Aktis Oncology , Inc. : Lilly Collaboration , Notable Backers Make for Intriguing IPO
Deal timeline
Announced
Jan 7, 2026 · smartkarma.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals. Figures and status may change as sources update.
Sources: smartkarma.com · Primary article · FireStrike proprietary index